环林B1:在胰腺癌中是一种潜在的预后和免疫生物标志物
Quan Chen1, Li Ouyang1, Qing Liu1
1Department of Pathology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China; Hospital Department, Hubei University of Chinese Medicine, Wuhan, China.
Biomolecules & biomedicine
|April 6, 2024
概括
环素B1 (CCNB1) 在大多数癌症中被上调,并与较差的存活率有关. 这项研究揭示了CCNB1作为多种癌症类型的潜在预后生物标志物和免疫治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 环素B1 (CCNB1) 对于细胞分裂和G2/M细胞周期过渡至关重要.
- CCNB1失调与各种癌症有关,包括胃癌,乳腺癌和肺癌.
研究的目的:
- 进行CCNB1.1的胰腺癌分析.
- 研究CCNB1.1的预后意义和免疫学作用.
主要方法:
- 使用了TCGA,GTEx,HPA,UALCAN,GEPIA,DNMIVD,STRING,Sangerbox和cBioPortal进行数据分析.
- 对基因表达,促进物甲基化,基因改变,免疫透和免疫调节剂进行了分析.
- 使用GraphPad Prism和R软件进行统计分析.
主要成果:
- 在28种癌症类型中,CCNB1表达显著升高.
- 在多种癌症类型中,增加的CCNB1表达与总生存率 (OS) 和无病生存率 (DFS) 的降低相关.
- 在CCNB1和免疫透,免疫调节剂,微卫星不稳定性 (MSI) 和瘤突变负担 (TMB) 之间发现了显著的关联.
结论:
- CCNB1显示出作为各种癌症的预后生物标志物的潜力.
- CCNB1可能成为癌症免疫治疗的有希望的标.
更多相关视频
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12.3K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.6K
相关概念视频
Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
M-Cdk Drives Transition Into Mitosis
5.6K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
